ANVISA registration 10269360503Valid until Jul 13, 2036

STREPTOCOCCUS

Name: STREPTOCOCCUS — ANVISA registration 10269360503
Creator: QUIBASA QUÍMICA BÁSICA LTDA
Keywords: STREPTOCOCCUS, STREPTOCOCCUS, FAMÍLIA BIOCLIN FAST STREP A, 10269360503, Risk Class III, ANVISA registration

ANVISA Registration Number: 10269360503QUIBASA - QUIMICA BASICA LTDAQUIBASA QUÍMICA BÁSICA LTDARisk Class III

Verified

Device names

Technical name: STREPTOCOCCUS
Commercial name: FAMÍLIA BIOCLIN FAST STREP A
Risk class: Class III

Registration details

Registration Number: 10269360503
Process Number: 25351070405202601
CNPJ: 19400787000107

Company information

Registration Holder: QUIBASA - QUIMICA BASICA LTDA
Manufacturer: QUIBASA QUÍMICA BÁSICA LTDA
Manufacturing Country: Brazil

Dates and status

Publication Date: Jul 13, 2026
Validity: 13/07/2036
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for STREPTOCOCCUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10269360503 and manufactured by QUIBASA QUÍMICA BÁSICA LTDA. The registration is held by QUIBASA - QUIMICA BASICA LTDA with validity until Jul 13, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.